|
|
||||||||
Nutritional epidemiology and public health |
1 From the US Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Division of Nutrition, Physical Activity, and Obesity (SEC, ZM, DSF, and MEC); National Center for Health Statistics (ACL and CLO) and National Center for Environmental Health (EG), Atlanta, GA
See corresponding editorial on page 1457.
| ABSTRACT |
|---|
|
|
|---|
Objective: We used data from National Health and Nutrition Examination Surveys 1988–1994 and 1999–2002 to examine recent anemia changes.
Design: We calculated the prevalence of anemia (hemoglobin < 11.0 g/dL at <24 mo, <11.1 g/dL at 24–59 mo, and <12.0 g/dL for women), iron deficiency anemia (anemia plus abnormal value
2: serum ferritin, transferrin saturation, and erythrocyte protoporphyrin), and high blood lead (
10 µg/dL) with anemia among children 12–59 mo and women 20–49 y in both surveys. Among women, we also calculated the prevalence of folate deficiency (erythrocyte folate < 317.2 nmol/L) with anemia and high C-reactive protein (>10 mg/L) with anemia. Multiple logistic regression was used to compare anemia prevalence between surveys, with control for race and age.
Results: Anemia declined significantly in children (from 8.0% to 3.6%; OR: 0.4; 95% CI: 0.3, 0.7) and women (10.8% to 6.9%; OR: 0.6; CI: 0.4, 0.7), but the prevalence of iron deficiency anemia did not change significantly in children (1.5% compared with 1.2%; OR: 0.7; 95% CI: 0.4, 1.5) or women (4.9% compared with 4.1%; OR: 0.8; 95% CI: 0.6, 1.1). Folate deficiency with anemia declined significantly in women (from 4.1% to 0.5%; OR: 0.1; 95% CI: 0.1, 0.2), but logistic regression models and standardization indicated that none of the known possible anemia causes could account for the decline in total anemia in children or women.
Conclusions: The prevalence of anemia declined significantly among US women and children between 1988–1994 and 1999–2002, but this decline was not associated with changes in iron or folate deficiency, inflammation, or high blood lead.
| INTRODUCTION |
|---|
|
|
|---|
Depending on the cause of anemia, the consequences of the condition are potentially serious and long-lasting. The consequences of iron deficiency anemia—including impaired cognitive and motor development (6-9) and increased susceptibility to lead poisoning (10, 11) in young children and impaired aerobic capacity and reduced work productivity (12, 13) in adults—have been widely reported, but anemia resulting from other nutritional deficiencies or inflammation can also reflect harmful health conditions. Among other possible causes of nutritional anemia, folate deficiency is associated with an increased risk of neural tube defects and may also be associated with adverse pregnancy outcomes, cardiovascular disease, depression, and dementia, whereas vitamin B-12 deficiency may be associated with an increased risk of heart disease and neuropathy (14-18). Anemia resulting from vitamin A deficiency may be linked with impaired immunity, growth, and vision (19). Anemia can also indicate inflammation caused by a variety of conditions, including infection, or it may occur in chronic illnesses such as chronic renal disease or endocrine disorders that can result in decreased erythropoiesis (4, 20).
Earlier data indicated that the prevalence of anemia declined in the 1970s and 1980s in US preschool children, but not among women of childbearing age (21, 22). The current burden of anemia in these 2 high-risk groups in the United States is unclear. In the present study, we used data from 2 recent National Health and Nutrition Examination Surveys (NHANES 1988–1994 and 1999–2002) to examine recent changes in total anemia prevalence. We also investigated between-survey changes in the prevalence of several types of anemia, including anemia associated with iron deficiency, folate deficiency, vitamin B-12 deficiency, vitamin A deficiency, high blood lead, and inflammation to assess whether these factors played a role in any observed changes in total anemia. Identification of a likely cause for changes in anemia could highlight existing public health interventions that have been successful or could identify new interventions that might be considered.
| SUBJECTS AND METHODS |
|---|
|
|
|---|
4 y during 1988–1994 and in children
3 y during 1999–2002. Total exclusions for missing laboratory data were as follows: n = 2026 children and n = 374 women for 1988–1994 and n = 776 children and n = 112 women for 1999–2002. After the exclusions, the final sample size for each survey was as follows: n = 2786 children and n = 4392 women for 1988–1994 and n = 1202 children and n = 1969 women for 1999–2002.
Phlebotomy refusal was the primary reason for missing laboratory data among children in both surveys (AC Looker, personal communication) (25). We compared the race/ethnicity distribution and income status of children excluded for having missing laboratory values with those of included children and found that whereas the race/ethnicity distribution was not significantly different in either survey, excluded children in both surveys were less likely to be of low income (family income
130% of the US poverty threshold) than were included children (1988–1994: 31% compared with 40%, chi-square test P < 0.01; 1999–2002: 34% compared with 44%, chi-square test P = 0.01).
In contrast, women excluded in 1999–2002 for having missing laboratory data were more likely to be of low income than were their included counterparts (39% compared with 25%, chi-square test P = 0.02). Excluded women were also more likely to be of non-Hispanic black race/ethnicity than were their included counterparts in both surveys (1988–1994: 21% compared with 12%, chi-square test P = 0.01; 1999–2002: 23% compared with 12%, chi-square test P < 0.01).
Finally, because serum vitamin B-12 and retinol were not measured for the entirety of both surveys, we constructed a subsample of women in each survey who also had data for serum vitamin B-12 (1991–1994: n = 2506; 1999–2002: n = 1968) and serum retinol (1988–1994: n = 4378; 1999–2000: n = 903). This subanalysis was not possible for children because both indicators were assessed only in children
4 y during 1988–1994 and in children
3 y during 1999–2002.
Laboratory methods
In both surveys, blood was collected from study participants
1 y by venipuncture. Hemoglobin was measured as part of a complete blood count done with a Coulter S-plus Jr in 1988–1994 and with a Coulter MAXM in 1999–2002 (both from Coulter Electronics, Hialeah, FL). The laboratory methods for other indicators were described in detail elsewhere (26-28). Briefly, serum ferritin was measured by using the Bio-Rad QuantImune Ferritin immunoradiometric assay (Bio-Rad Laboratories, Hercules, CA), whereas transferrin saturation was calculated as serum iron divided by total-iron-binding capacity, as measured by a Centers for Disease Control and Prevention modification of the automated Technicon AAII-25 ferrozine colorimetric method (Alpkem TFA analyzer; Alpkem, Clackamas, OR). Free erythrocyte protoporphyrin was measured in whole blood by fluorescence extraction by using a modification of the Sassa method. Red blood cell folate was measured with the QuantaPhase-I Folate Radioassay Kit (Bio-Rad Laboratories) from 1988 to 1991 and with the QuantaPhase-II kit from 1991 to 1994 and from 1999 to 2001. The QuantaPhase-II kit reflected recalibration of the assay for which appropriate adjustments were made to the 1988–1991 values to make them comparable with the 1991–2001 values before public release. The QuantaPhase II assay also measured serum vitamin B-12. During both surveys, serum CRP was measured by latex-enhanced nephelometry (lower limit of detection: 0.2 mg/L). Blood lead was measured by atomic absorption spectroscopy, and serum retinol was measured by HPLC.
Cutoffs and definitions
Hemoglobin cutoffs used to define anemia and cutoffs used for defining abnormal values for indicators of iron status, blood lead, red blood cell folate, CRP, retinol, and vitamin B-12 are presented in Table 1
. We defined iron deficiency as having an abnormal value for
2 of the 3 following indicators: serum ferritin, transferrin saturation, and erythrocyte protoporphyrin (29). We defined iron deficiency anemia as iron deficiency plus anemia.
|
2 of these conditions with anemia. We also calculated the prevalence of vitamin B-12 deficiency with anemia and the prevalence of vitamin A with anemia among women in the sub-sample. We then used multiple logistic regression to compare overall anemia prevalence and type-specific anemia prevalence between the surveys for children and women, controlling for race/ethnicity, sex (in the children's models), and age. We further adjusted the children's overall anemia model for iron deficiency and high blood lead and the women's overall anemia model for iron deficiency, high blood lead, folate deficiency, and high CRP to assess the role of these potential causes of anemia in any observed change in anemia prevalence.
Because preliminary analyses and recently published data (36) indicated that the prevalence of folate deficiency declined significantly among women of childbearing age between the surveys, we used direct standardization to examine the possible effect this decline had on the prevalence of anemia between the surveys (37).
Finally, to investigate the possibility of a systematic difference in hemoglobin measurement between the surveys, we constructed mean-difference plots for hemoglobin among women by subtracting hemoglobin values at each percentile in 1988–1994 from hemoglobin values at the corresponding percentile in 1999–2002 and plotting this difference on the y axis, with hemoglobin in the first survey on the x axis (38).
| RESULTS |
|---|
|
|
|---|
130% of the Federal Poverty Threshold than did women in 1988–1994 (P = 0.05; Table 2
|
|
2 types of anemia declined by more than a percentage point. Further analysis showed that >70% of the women in 1988–1994 who had 2 types of anemia had concurrent iron and folate deficiency (data not shown). High blood lead, inflammation, vitamin A deficiency, and vitamin B-12 deficiency concurrent with anemia were rare among women in both surveys (<1%; subsample data not shown).
Type-specific anemia patterns remained when we stratified by race/ethnicity category (Table 4
). The prevalence of anemia declined significantly in each race/ethnicity group, but the prevalence of iron deficiency anemia did not change significantly in any group and remained high among both black (12%) and Mexican American (8%) women. The prevalence of folate deficiency with anemia declined significantly in each race/ethnicity group.
|
Preliminary analyses showed that the prevalence of folate deficiency among women in our sample was 36% in 1988–1994 and 4.5% in 1999–2002. To assess further whether this decline played a role in the decline in anemia that we observed, we used direct standardization and found that if the prevalence of folate deficiency had remained 36% in both surveys, the prevalence of anemia would have declined from 11% to 8%, similar to the decline in unadjusted prevalences of 11% to 7% (Table 3
). Furthermore, additional analyses showed that among nonfolate-deficient women in each survey, the prevalence of anemia also declined from 11% to 7% between the surveys.
To assess the possibility of a systematic error in hemoglobin measurement, we constructed mean-difference plots for hemoglobin among women by subtracting hemoglobin values at each hemoglobin percentile in 1988–1994 from the hemoglobin values at the corresponding percentile in 1999–2002 (Figure 1
). We then plotted this difference (in g/dL) along the y axis with hemoglobin in 1988–1994 along the x axis. For example, among black women, the 10th, 50th, and 90th percentiles of hemoglobin were 11.1, 12.6, and 13.8 g/dL, respectively, in the first survey and were 11.1, 12.7, and 14.1 g/dL, respectively, in the second survey. The differences in these percentile values (1999–2002 minus 1988–1994) were 0.0, 0.1, and 0.3 g/dL, which fall along the line in the middle panel of the Figure 1
. We found that the magnitude of change in hemoglobin values differed by race/ethnicity group, with a greater increase in hemoglobin observed among white (median difference: +0.34) and Mexican American (+0.37) women than among black women (+0.13).
|
| DISCUSSION |
|---|
|
|
|---|
The majority of anemia among children in both surveys was not associated with iron deficiency or high blood lead. The observed low prevalence of iron deficiency anemia among US preschool children was likely the result of concerted efforts to prevent iron deficiency anemia in this vulnerable age group, including iron fortification of infant formulas and establishment of The Special Supplemental Nutrition Program for Women, Infants, and Children in the early 1970s (21, 39-41). Blood lead concentrations have also declined significantly since the 1970s, largely because of the removal of lead from gasoline and soldered cans (42, 43).
The cause of the decline in the prevalence of anemia among children between the surveys is thus unclear, and, unfortunately, the lack of data on folate, vitamin B-12, serum retinol, and CRP among children surveyed in this age group limited our investigation of potential causes. Others have reported the importance of common infections, including upper respiratory tract infection, otitis media, and gastroenteritis as causes of anemia in preschool-aged children (20), but whether the frequency of these infections decreased sufficiently between the surveys to contribute to the decline in all-cause anemia among children is not known.
Iron deficiency anemia was the predominant type of anemia among women in both surveys and was most prevalent in black and Mexican American women. The cause of the persistently high prevalence among women in these race/ethnicity groups merits further attention, but may be due to lower socioeconomic status, lower attained education, or higher parity, all of which are associated with iron deficiency in women of childbearing age (30). Nevertheless, the prevalence of iron deficiency anemia did not change significantly between the 2 surveys among all women or in any race/ethnicity group and thus seems unlikely to explain the significant decline in the prevalence of all-cause anemia.
We did observe a significant decline in the prevalence of concurrent folate deficiency and anemia among women, but this decline appeared to be the result of concomitant, but unrelated, declines in both folate deficiency and anemia. Several authors have reported multiple beneficial effects of the 1998 folic acid fortification of all US enriched cereal-grain products, including a reduced prevalence of neural tube disorders (44, 45) and lower concentrations of homocysteine (46, 47). No study has evaluated the effect of folic acid fortification on anemia. The timing of NHANES 1988–1994 (before fortification) and 1999–2002 (after fortification) permitted us to evaluate such an association, but regression and standardization results failed to prove a relation.
Another possible cause of the observed decline in anemia was a systematic difference in hemoglobin measurement between the surveys, introduced by the use of 2 different models of Coulter counter. A direct investigation, in which both instruments are used to measure hemoglobin on the same sera samples, was not possible because the instruments used in 1988–1994 were no longer available. We instead used an indirect approach to assess this possibility by subtracting hemoglobin values at various percentiles of the first survey from hemoglobin values at the corresponding percentiles of the second survey and then plotting this difference on the y axis with hemoglobin in the first survey on the x axis. These results suggest that a systematic difference in hemoglobin concentrations between the 2 surveys did not play a major role in the observed decline in the prevalence of anemia, because the patterns and magnitude of hemoglobin differences were different for each race/ethnicity group.
Important health trends over the past 3 decades, specifically the decline in cigarette smoking (48) and the increase in overweight and obesity (49, 50), have the potential to affect anemia rates, but likely in a direction opposite of what we observed. Among women in NHANES II, smokers had a significantly higher mean hemoglobin concentration than did nonsmokers and a lower prevalence of anemia (51), but the declining smoking rates between 1988 and 2002 (48) would be more consistent with a lower hemoglobin concentration and a higher prevalence of anemia. Similarly, overweight may be associated with an increased risk of iron deficiency (52), whereas a high prepregnancy body mass has been found to be associated with a greater risk of postpartum anemia (53), but both would be consistent with an increase, rather than with a decline, in anemia.
A limitation of our study was the possibility of selection bias introduced by the large number of children with missing laboratory data, due primarily to phlebotomy refusal. Although the race/ethnicity of children with missing laboratory data was not significantly different from included children, included children were significantly more likely to be of low income, which potentially inflated the anemia estimates. However, the relative amount of bias by income in the 2 surveys appears similar (1988–1994: 31% low income in the excluded sample compared with 40% in the included sample; 1999–2002: 34% compared with 44%). This finding suggests that the difference in prevalence between the surveys observed in our study was unlikely to be seriously affected.
Whereas a much smaller proportion of women than children were excluded because of missing laboratory values, excluded women in both surveys were more like to be of non-Hispanic black race/ethnicity than were included women, perhaps leading to an underestimation of total anemia and/or iron deficiency anemia. Again, however, the relative amount of bias by race in the 2 surveys appeared to be similar (1988–1994: 21% low income in the excluded sample compared with 12% in the included sample; 1999–2002: 23% compared with 12%). Excluded women also tended to have a higher prevalence of poverty in 1999–2002. Adjustment for poverty in multivariate models for anemia, however, did not change the OR estimates, which made it unlikely that this finding significantly affected our overall results.
Our restricted ability to assess inflammation was an additional limitation. CRP tends to peak and diminish rapidly and thus may not reflect more chronic inflammatory conditions (54). We were also unable to account for other possible causes of anemia, including hemoglobinopathies, cancer, and aplastic anemia resulting from reduced red blood cell production; however, these conditions were probably not common in the children and young adult women.
In summary, we observed a significant decline in the prevalence of all-cause anemia between 1988–1994 and 1999–2002. Whereas the explanation for the decline remains unclear, the reduced anemia burden among US children and women is notable in that anemia itself is associated with multiple adverse health outcomes, including mild-to-moderate mental retardation in children (55) and low infant birth weight and increased risk of preterm birth in pregnant women (56). Although iron deficiency anemia was not prevalent among preschool-aged children in either survey, it remains prevalent among women of childbearing age, particularly among black and Mexican American women. Further investigation of the lack of association between folate deficiency and anemia may warrant further investigation.
| ACKNOWLEDGMENTS |
|---|
The authors' responsibilities were as follows—MEC and ACL: conducted the preliminary analyses; SEC, MEC, DSF, ZM, ACL, and CLO: developed the analytic plan; EG: reviewed the laboratory components and conducted relevant quality-control analysis; SEC: wrote the manuscript; and SEC and DSF: conducted the analyses. All authors reviewed the manuscript. None of the authors had a conflict of interest.
| REFERENCES |
|---|
|
|
|---|
Related articles in AJCN:
This article has been cited by other articles:
![]() |
H. A Eicher-Miller, A. C Mason, C. M Weaver, G. P McCabe, and C. J Boushey Food insecurity is associated with iron deficiency anemia in US adolescents Am. J. Clinical Nutrition, November 1, 2009; 90(5): 1358 - 1371. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H Mahoney Jr Anemia in at-risk populations--what should be our focus? Am. J. Clinical Nutrition, December 1, 2008; 88(6): 1457 - 1458. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |